Bleichroeder LP 13D and 13G filings for Cellectar Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 10:46 am Purchase | 2025-09-30 | 13G | Cellectar Biosciences, Inc. CLRB | Bleichroeder LP | 200,000 6.080% | 200,000 (New Position) | Filing |